Abstract-Cells inside a 3D matrix (such as tissue extracellular matrix or biomaterials) sense their insoluble environment through specific binding interactions between their adhesion receptors and ligands present on the matrix surface. Despite the critical role of the insoluble matrix in cell regulation, there exist no widely-applicable methods for quantifying the chemical stimuli provided by a matrix to cells. Here, we describe a general-purpose technique for quantifying in situ the density of ligands for specific cell adhesion receptors of interest on the surface of a 3D matrix. This paper improves significantly the accuracy of the procedure introduced in a previous publication by detailed marker characterization, optimized staining, and improved data interpretation. The optimized methodology is utilized to quantify the ligands of integrins a 1 b 1 , a 2 b 1 on two kinds of matched porous collagen scaffolds, which are shown to possess significantly different ligand density, and significantly different ability to induce peripheral nerve regeneration in vivo. Data support the hypothesis that cell adhesion regulates contractile cell phenotypes, recently shown to be inversely related to organ regeneration. The technique provides a standardized way to quantify the surface chemistry of 3D matrices, and a means for introducing matrix effects in quantitative biological models.
INTRODUCTION
Cells in vivo interact extensively with 3D matrices, such as the native extracellular matrix (ECM) of tissues or implanted biomaterials. Cells sense and respond to their insoluble microenvironment through specific binding interactions between their adhesion receptors and ligands present on the matrix surface.
The effects of such cell-matrix interactions have been shown to affect strongly key cell phenotypes. Examples include the role of ECM in tumor progression, 2, 23 and the ability of certain biomaterials to induce regeneration, 33 or control stem cell fate. 15 A prerequisite for cell-matrix interactions is the presence of appropriate ligands for cell adhesion receptors on the matrix. Many studies have focused on the identity of adhesion ligands present on ECM biomolecules, particularly ligands for integrins, the major family of adhesion receptors. 16 In particular, it has been shown that cells bind to collagen type I (the major ECM component of many tissues) mainly via collagenbinding integrins, which recognize several ligands on the collagen molecule 6, 29 . Although there is significant progress in characterizing elementary binding interactions of adhesion receptors to their ligands on ECM molecules, 24 the chemical environment sensed by cells inside tissue stroma or biomaterial grafts has been not been studied in detail yet.
The surface chemistry of a matrix (defined here as the density of ligands for particular adhesion receptors available to cells) determines which adhesion receptors can be utilized by cells, controls the perception of the cell about its insoluble environment, and induces intracellular signaling. 25 Despite its importance, the vast majority of published studies on cell-matrix interactions do not report the surface chemistry of the utilized matrix. Few studies report instead the mass of adsorbed matrix biomolecules on cell culture dishes, 10, 22 ,31 a measurement not necessary analogous to its surface chemistry. A key reason for this omission is the lack of appropriate methods for quantifying the surface chemistry of the insoluble microenvironment of cells. The few available methods are often nonquantitative, and not widely-applicable, since they can be applied only in RGD-functionalized synthetic biomaterials. 3, 12, 19 Some spectroscopic techniques can quantify chemical groups on the surface of biomaterials, 18, 20 however these measurements cannot be converted straightforwardly into density of ligands of particular adhesion receptors.
This study describes in detail a technique for quantifying the density of ligands of a particular adhesion receptor on the surface of a 3D matrix in situ. It improves significantly the accuracy of the concept introduced in a previous publication 30 in three ways: (1) detailed characterization of fluorescent analogs of the two major collagen-binding integrins (a 1 b 1 , a 2 b 1 ), (2) optimized marker staining protocols that increase sensitivity and minimize background staining, (3) estimation of ligand density via a binding model that considers the nature of soluble marker to an 3D matrix. The methodology is utilized to quantify the ligands of integrins a 1 b 1 , a 2 b 1 on two matched porous collagen scaffolds, similar to grafts used clinically in induced peripheral nerve regeneration. The effects of biomaterial surface chemistry were investigated by imaging ex vivo sections of transected peripheral nerves treated with the two scaffolds and focusing on the effects of surface chemistry on cell-scaffold adhesion and wound contraction, a phenotype proposed to affect critically the final wound healing outcome. 33 
MATERIALS AND METHODS

Scaffold Fabrication
Sheets of porous collagen scaffolds were fabricated by freeze-drying a 0.5% w/v micro-fibrilar collagen I suspension using published protocols. 27 The dry outcome of freeze-drying (scaffold A) is cross-linked by either dehydro-thermal treatment (DHT) at 120°C for 48 h at 50 mTorr (scaffold D) or chemically via treatment with 14.4 mM EDC and 5.6 mM NHS for 1 h at room temperature (scaffold E), Fig. 1a .
Expression and Purification of I Domains
Soluble fluorescent analogs of the two major collagen-binding integrins (a 1 b 1 , a 2 b 1 ) were prepared by fusing the tetracysteine (TC) tag WDCCPGCCK at the N-terminus of the I domains of the a subunit of the corresponding integrin by PCR.
1 GST-I domain fusion proteins were expressed in BL21 e-coli, purified via affinity chromatography, and treated with thrombin to remove the GST domain following published protocols. 6 ,29 I domain solutions were carefully concentrated via filter centrifugation in assay buffer (PBS, 2 mM MgCl 2 , 2 mM TCEP, 0.02% tween20), stored at 4°C, and used within 20 days. The concentration and purity of purified I domain solutions was evaluated via 280 nm absorption and SDS-PAGE.
Circular Dichroism Spectroscopy
The contribution of secondary structures in purified I domain solutions was estimated by circular dichroism spectroscopy in an Aviv Model 202 CD spectrometer (Aviv Biomedical) using a far-UV quartz cuvette (New Era enterprises Inc). I domain solutions were diluted in assay buffer so that their 280 nm absorption was approximately 0.17. The measured ellipticity h(k) was buffer corrected and converted into mean residue ellipticity h mrw k ð Þ. Secondary structure contribution was estimated by three soft ware tools (SELCON3, CONTINLL, CDSSTR, Colorado State University). For tag-free I domains secondary structure predictions were compared with secondary structures annotated in X-ray structures 1QCY and 1AOX.
Surface Plasmon Resonance
The binding of purified recombinant I domains to collagen I or gelatin was evaluated via the surface plasmon resonance (SPR) assay in a BIACORE T100 (GE Healthcare Bio-Sciences AB) following previously published protocols. 6 1200 RU of ligands (30 lg/ml collagen I from tail tendon (BD biosciences) or gelatin (collagen I denatured by heating at 65°C for 30¢) in 10 mM sodium acetate pH 4.5 were immobilized on the surface of CM5 chips (GE Healthcare): collagen I in chambers 2 and 4, gelatin in chamber 3, no ligand in chamber 1. The binding of each analyte to its immobilized ligands was studied by flowing 40 lL/min solutions of increasing analyte concentration (0.05 to 6 lM in HBS-P + supplemented with 1 mM MgCl 2 ) for 3 min, followed by dissociation in 40 lL/min running buffer for 12 min, and regeneration by 20 lL/min regeneration buffer (HBS-P+, 10 mM EDTA, 0.01% v/v SDS) for 1 min. Each condition was performed in duplicates. Raw sensorgrams were processed either by custom-written software (Supplementary Material) or by the BiaEval software (GE Healthcare). Data processing includes compensation of various artifacts, and global fitting of corrected sensorgrams into a 1:1 binding model that describes the kinetics of the detected SPR signal R t ð Þ: 
where k on and k off are the association and dissociation rates of the analyte-ligand binding reaction, I 0 is analyte concentration, M I and M C are the MW of I domain and collagen respectively, and R max is the maximum steady state signal achieved when all ligands per collagen molecule are bound to analyte.
Ligand Density Assay
Ligand density measurements took place in cylindrical scaffold samples (2 mm diameter, 3 mm height) in PCR tubes. Scaffold samples were hydrated in PBS, blocked with 100 lL superblock in PBS (Thermo scientific) for 3 h at 4°C, treated with stained TC-tagged I domain solutions (sometimes supplemented with nontagged I domains) overnight at 4°C, and imaged in a multi-photon microscope (Fig. 3a) . Each binding assay consists of two distinct experiments. In ''binding'' experiments, I domain buffer is supplemented with 2 mM MgCl 2 . In ''control'' experiments, I domain buffer is supplemented with 10 mM EDTA. TC-tagged I domain staining is done by treatment with 1 mM TCEP for 2 h at 4°C and then with 5% excess FlAsH-EDT 2 in the presence of 1 mM bme and 1 mM TCEP for 3 h at 4°C. Careful removal of unbound FlAsH from FlAsH-stained I domains via gel filtration (micro bio-spin 6, Biorad Laboratories Inc.) prevents nonspecific binding of FlAsH to blocking agents bound on the matrix, which causes background fluorescence and induces experimental noise. Removal of unbound FlAsH also eliminates the need for a BAL wash, a step included in the initial procedure 30 that reduces accuracy (BAL affects specific binding of FlAsH to TC-tagged I domans).
3D images of scaffolds on glass-bottom dish treated with fluorescently-labeled I domains were acquired by a spectral multi-photon microscope. 5 Imaging parameters: image planes are located 10 to 30 lm away from the scaffold surface, 4.8 mW laser power, 775 nm laser wavelength, 40 ls pixel acquisition time, 256 9 256 pixels, 0.21 lm pixel size, Zeiss C-apochromat 40 9 1.2 NA water immersion objective lens. For each experiment two z-stacks are acquired per sample. After spectral unmixing and image segmentation, ligand density measurements are based on the FlAsH emission of pixels located at the outer surface of scaffold struts (Supplementary Material). This emission is converted into equivalent FlAsH concentration using a standard curve. In contrast to the earlier preliminary publication where ligand density was expressed in units of ligands/lm 230 here the density of ligands is expressed in Molar units since new experimental data showed that I domains can slowly diffuse and bind ligands inside the whole scaffold strut volume.
Binding Model
The estimation of adhesion ligand density L 0 is based on a 1:1 binding model that describes the binding of soluble I domains to their immobilized ligands present in the 3D matrix. In this case it can be shown (Supplementary Material) that L 0 (in units of M) can be estimated as:
where B ss I 0 ð Þ is the measured concentration of I domains bound on a matrix when the matrix is treated with an I domain solution of concentration I 0 . The slope dB ss dI 0 is estimated from binding assay data. k D ¼ k off =k on is the dissociation constant of I domain binding to collagen, estimated from BIACORE data.
Animal Experiments
NIH guidelines (85-23 Rev. 1985) were observed for all surgical procedures. 27 Adult female Lewis rats were anesthetized, the sciatic nerve was anesthetized topically and transected. The nerve stumps were inserted into the ends of a collagen conduit, leaving a 15 mm gap between the nerve stumps. The gap is then filled with saline, and the scaffold is secured using nylon sutures. Animals were sacrificed 1 or 9 weeks post-injury by CO 2 inhalation. The excised tissue was fixed in 4% paraformaldehyde in on ice for 8 h, immersed in 30% sucrose solution overnight, immersed in Optimal Cutting Temperature medium, flash frozen in liquid nitrogen, cryo-sectioned at 10 lm thickness on a microtome, and stored at 220°C. Sections were later thawed at room temperature for 30 min, washed twice in TBST for 10 min, blocked and permeabilized in blocking solution (Dako) supplemented with 0.3% Triton X100 for 1 h at room temperature, treated with AlexaFluor488-conjugated wheat germ agglutinin (Life Technologies) overnight at 4°C, washed twice in PBS for 10 min, counterstained with 10 ng/ml DAPI and 1:100 rhodamine-phalloidin (Life Technologies), and coversliped.
Low-magnification images of labeled sections were acquired in an Olympus IX81 fluorescence microscope equipped with an ORCA CCD detector (Hamamatsu, Japan) using a Fluar 49 objective lens. High-magnification images were acquired by a spectral multi-photon microscope. 5 Imaging parameters: 8 mW laser power, 775 nm laser wavelength, 40 ls pixel acquisi-tion time, 0.21 lm pixel size. The signal contributions of emission sources was resolved by spectral unmixing.
RESULTS
The methodology developed for quantifying the density of ligands for a particular adhesion receptor on a 3D matrix consists of three steps: (1) Development of soluble fluorescent analogs (markers) of each adhesion receptor of interest via genetic engineering. In contrast to antibodies which recognize single epitopes that are not necessarily related to adhesion ligands, such fluorescent analogs bind to all ligands of the corresponding receptor with similar affinity as the receptor of interest.
(2) Conduct a series of binding assays of the markers on the 3D matrix, where the density of fluorescent markers bound on their ligands on the matrix is quantified by 3D microscopy, and (3) Estimate the density of adhesion ligands on the matrix by fitting the binding assay data to an appropriate binding model.
The technique is demonstrated by quantifying the density of adhesion ligands for the two major collagenbinding integrins (a 1 b 1 , a 2 b 1 ) in two kinds of matched porous collagen scaffolds. These biomaterials were chosen because they recently showed remarkably different ability to induce regeneration in a standardized animal model of peripheral nerve (PN) injury 9 weeks post-injury. 27 Scaffold D is similar to the FDA-approved devices Integra TM and Neuragen
TM
, which are applied clinically in patients with severe burns and limb paralysis respectively. 4, 11 Scaffolds D and E have identical pore geometry and chemical composition (they are fabricated using the same protocol), Fig. 1a , but differ in the final cross-linking treatment. Scaffold D has been cross-linked by dehydro-thermal treatment (DHT). Scaffold E has been cross-linked chemically by EDAC and NHS. As baseline reference, scaffold A was the outcome of freeze-drying without cross-linking.
For each integrin of interest (a 1 b 1 , a 2 b 1 ) two kinds of soluble markers were expressed, and affinity purified: the non-fluorescent marker (the I domain of integrin a i subunit), and the same I domain tagged with a tetracysteine (TC) motif. The I domain of the a subunit of a collagen-binding integrin recognizes and binds to the same adhesion ligand as does the corresponding integrin. 6, 16, 29 When the TC tag binds the biarsenical dye FlAsH, the complex becomes fluorescent, 1 generating soluble fluorescent markers of the ligands of the corresponding integrin. The TC-FlAsH system was preferred over fusing I domains to a fluorescent protein, due to its small size (1 kDa) that was expected to affect the conformation-sensitive binding affinity of I domains much less.
1 SDS-PAGE stained by FlAsH reveals that only TC-tagged I domains become fluorescent upon FlAsH treatment (Fig. 2a) .
The properties of purified I domains were evaluated via circular dichroism (CD) spectroscopy, and surface plasmon resonance analysis of their binding to collagen (BIACORE assay). Predictions of secondary structure based on CD data suggest that the TC tag slightly decreases the contribution of a-helices and bsheets and increases the contribution of turns and random coil, in agreement with the published hairpin structure of the TC tag. 21 Adding the TC tag affects acquired CD spectra h mrw k ð Þ mostly below 200 nm (Fig. 2b) . CD analysis tools provide similar predictions of secondary structure contribution (Table S1 ). Estimated contributions for tag-free I domains agree well with the secondary structure annotated in published Xray structures. Fitting BIACORE binding data (Figs. 2c and 2d) (Table S2 ). BIACORE data show that binding of native non-tagged I domains (denoted as a i , where i = 1, 2) and TC-tagged I domains (denoted as TC-a i , i = 1, 2) to collagen have similar kinetics (TC tag causes small k D increase) and magnitude. Finally, both native I domains and TC-tagged I domains bind to collagen significantly more than gelatin (Figs. 2c  and 2d ), in agreement with the known dependence of integrin-collagen binding on collagen conformation. 9, 29 The density of adhesion ligands for each receptor of interest and in each scaffold type was estimated based on a series of in situ binding experiments. Samples of collagen scaffolds were blocked and treated with solutions of fluorescent markers of increasing concentration in the absence or presence of non-fluorescent markers. Binding experiments took place in the presence of either 2 mM Mg +2 (''signal'' experiments) or 10 mM EDTA (''control'' experiments). After overnight incubation in fluorescent marker solution, biomaterials were imaged in a spectral multi-photon microscope (Fig. 3a) . The detected images contain the emission of both collagen and FlAsH, which were separated by spectral unmixing (Fig. 3b) . Results show that FlAsH emission in the presence of 10 mM EDTA was always much lower compared to the emission in the presence of 2 mM MgCl 2 (Fig. 3b) . The effect of Mg +2 on TC-tagged I domain binding to its ligands on collagen agrees with the published divalent cation-dependent mechanism of integrin-ligand binding and has been reported in previous studies of I domain binding to collagen. 6, 29 Compared to the preliminary data presented in a previous publication, 30 the optimized staining protocol utilized here resulted in 49 higher FlAsH emission with minimal background signal (Fig. 3b) . The density of fluorescent markers that bind specifically onto ligands on the scaffold was estimated by subtracting the FlAsH emission of ''control'' experiments from the emission of ''signal'' experiments (Fig. 4a) . Increasing the concentration of non-fluorescent markers in the presence of constant concentration of fluorescent markers reduced the density of fluorescent markers bound on the scaffold, suggesting saturable specific binding of I domains on the scaffold (Fig. 4b) 2. Biochemical characterization of the purified I domains and TC-tagged I domains. (a) SDS-FlAsH-PAGE analysis of purified fractions of non-tagged and TC-tagged I domains before and after thrombin cleavage. Samples were reduced by TCEP and stained by FlAsH before denaturing and loading. 1 After electrophoresis, the gel was imaged first in a fluorescent imager (bottom), and then it was stained using coomasie blue and imaged in a conventional imager (top). STD: protein standards. FIGURE 3 . Optical-based ligand density quantification in 3D matrices using fluorescent analogs of adhesion receptors. (a) Schematic of the procedure for quantifying the density of adhesion ligands on a 3D matrix (b) Representative data of the imaging-based binding assay utilized for quantifying the surface chemistry of a matrix in situ. 16-channel spectral data shown after the separation of collagen and FlAsH emission by spectral unmixing. Data display scaffold struts (detected by the collagen autofluorescence) in the red channel and FlAsH emission (from labeled TC-tagged I domains bound to collagen ligands) in the green channel. Scaffold samples have been treated with either 6 lM fluorescently labeled TC-a 1 (rows 1, 2) or 6 lM TC-a 2 (rows 3-4) in the presence of 2 mM MgCl 2 (''signal'' experiments, rows 1 and 3) or 10 mM EDTA (''control'' experiments, rows 2 and 4). Bar: 20 lm. (Fig. 4c) . These data showed that EDAC-NHS crosslinking reacts with and effectively destroys a 1 b 1 , a 2 b 1 ligands in scaffold E, in agreement with the known chemical mechanism of EDAC (attacks carboxyl groups), and the presence of carboxyl groups in key acidic residues of a 1 b 1 , a 2 b 1 ligands. 24 On the other hand, DHT cross-linking appeared not to affect the surface chemistry of the scaffolds since the measured ligand density of scaffolds D and A were not significantly different.
The importance of the surface chemistry of a 3D matrix is demonstrated by quantifying its effects in the application of collagen scaffolds in PN regeneration. It has been shown that certain porous collagen scaffolds can induce regeneration in skin and PN, and that this regenerative ability depends strongly on specific scaffold features. 27, 34 The underlying molecular details of this dependence are not known yet. Experimental data from skin 34 and PN regeneration 27 and recent observations in African mice that spontaneously regenerate their skin 26 suggest that regenerative activity correlates with down-regulation of wound contraction. The requirement for cells to adhere to their surrounding matrix in order to apply significant contractile forces suggests that the surface chemistry of a biomaterial may affect its regenerative activity via regulating wound contraction. In order to get evidence that could support this hypothesis, a follow-up study of the previous 9-week animal study, 27 was designed: rat sciatic nerves were transected, the resulting stumps were separated by 15 mm, inserted in tubular collagen scaffolds D or E (Fig. 5a) and harvested 1 or 9 weeks post-injury. The 9 week time point serves as an indicator of the final wound healing outcome. 7 The 1 week time point provides evidence about the effects of the biomaterial during the critical early wound healing response. 32 Low magnification images of PN regenerates harvested 1 or 9 weeks post-injury (Figs. 5b and 5c ) show an assembly of contractile cells (capsule) that surrounds the newly formed nerve tissue (regenerate). The mechanical forces applied by capsule cells are the origin of macroscopic wound contraction. 33 The diameter and number of axons that manage to cross half the gap 9 weeks post-injury have been proposed as quality metrics of the wound healing outcome. The nerve regenerate in animal group D had a significantly larger diameter compared to animal group E both 1 and 9 weeks post-injury, in agreement with its increased regenerative activity. 27 Furthermore, regenerates in animal group D were surrounded by a significantly thinner capsule compared to group E (82.9 ± 8.6 lm vs. 158.0 ± 31.3 lm 1 week post-injury, 31 ± 5 lm vs. 73 ± 18 lm 9 weeks post-injury, n = 3), a sign of reduced wound contraction (Figs. 5b and 5c ). In both animal groups, the contractile cell capsule (highlighted as ''C'') has already filled the volume between the regenerate and the scaffold as soon as 1 week postinjury, suggesting fast kinetics of wound contraction that could potentially have significant effects in the delicate fibrin bridge that connects the two nerve stumps during the early phase of wound healing. 32 Low magnification images suggest two possible ways that scaffold surface-chemistry that could affect the wound healing outcome. First, they show that capsule cells have different extent of contact with the surrounding scaffold. In group D capsule cells make firm contact with the surrounding scaffold both at 1 and 9 weeks post-injury around the whole perimeter of the regenerate (Figs. 5b and 5c left) . On the other hand, during cryo-sectioning of samples from animal group E there were frequent artifacts (tears) in the capsule-scaffold interface, in agreement with the hypothesis that capsule cells are not strongly attached to the surrounding scaffold E. 9 weeks post-injury in animal group E the capsule and the scaffold are usually separated by void volume suggesting loss of contact or poor cell-scaffold adhesion (Figs. 5b and 5c right) . Second, the extent of cell migration inside the two kinds of scaffolds is very different. In group D a significantly larger number of cells infiltrates inside the scaffold both at 1 and 9 weeks post-injury compared to group E (Fig. 5c) , suggesting that cells cannot migrate inside scaffold E despite the fact that is made of collagen I.
High-magnification multi-photon imaging was then utilized to zoom in the same cross sections and study in detail the region where capsule cells bind to the collagen scaffold. High magnification images show that the capsule consists of circumferentially-oriented collagen fibers (visualized via the second harmonic emission of tissue collagen) and actin-rich contractile cells (Fig. 6) . The different extent of cell-scaffold interactions is again evident. In group D contractile cells in the outer layer of the capsule bound extensively on the scaffold inner lumen and their long axis intersected with the scaffold outline, indicating that cells transmit forces to the scaffold (Fig. 6 left) . By contrast, in group E capsule cells in the outer capsule layer stain strongly for actin, were much more elongated (both signs of increased contractility), and their long axes were strongly aligned in the circumferential direction. These observations suggest that in animal group E capsule cells apply forces to each other rather than to the surrounding scaffold. The strictly circumferential orientation and high cell aspect ratio is observed in animal group E both at 1 and 9 weeks post-injury and is independent on whether the capsule is in contact with the surrounding inner lumen of the scaffold (Fig. 6  right) .
High resolution imaging also reveals that in group D, many individual cells managed to migrate inside the scaffold (as soon as 1 week post-injury) and bind to its struts in a spindle-like shape. These cells are contractile (stain brightly for actin) and synthesize new collagen fibers, which are detected based on their bright second harmonic emission (Fig. 6 bottom left) . On the other hand, in animal group E the scaffold area in the proximity of its inner lumen lacks any infiltrating cells (Fig. 6 bottom right) . While several studies have focused on the molecular interactions between cell adhesion receptors and ECM molecules in vitro, 6,29 it has not been so far possible to quantify the extent of these interactions in the native 3D insoluble microenvironment where cells actually interact with these molecules. It is expected that the magnitude of chemical stimuli provided by a matrix to cells depends on its chemical composition, component cross-linking, chemical treatments, nanoscale topology and spatial arrangement of matrix molecules in 3D space. 18, 22, 28 Here, the technique utilizes TC-tagged I domains as fluorescent analogs of collagen-binding integrins. I domains have been extensively utilized to study integrin binding to collagens. 6, 21, 29 Although most studies focus on I domain binding to tropocollagen, collagen I in tissues always forms super-molecular structures such as fibrils and fibers. A related study revealed that fibril formation reduced the affinity of I domains to collagen. 17 This study goes a step further, and utilizes fluorescent I domains to quantify in situ for the first time the surface chemistry of two matched scaffolds made of microfibrillar collagen I (the fibril nature of collagen causes the D-banding shown in Fig. 1c ).
Biochemical characterization of purified I domains overall suggest that the addition of the TC tag makes I domains fluorescent without significantly disturbing their secondary structure and binding characteristics to collagen (Fig. 2, Tables S1, S2 ). Data show that a 2 was affected more by the addition of the TC tag compared to a 1 . Optimized FlAsH staining of TC-tagged I domains improved significantly the sensitivity and accuracy of the method compared to the preliminary procedure 30 and provided the sensitivity required to discriminate 3D matrices of different surface chemistry. Results show that scaffold D (cross-linked by DHT) provides to cells 204.9 ± 41 lM a 1 b 1 and 248.3 ± 61 lM a 2 b 1 ligands. This is approximately one order of magnitude higher compared to the density of ligands provided by scaffold E (cross-linked by EDC and NHS) and not significantly different compared to the density of ligands provided by the uncross-linked scaffold. These results highlight a significant effect of the cross-linking method on biomaterial surface chemistry.
Although the results presented focus on ligands of integrins a 1 b 1 , a 2 b 1 on porous collagen scaffolds, the methodology can be extended to quantify the ligands for different types of adhesion receptors in different kinds of cell-free matrices such as biomaterials, physiologic vs. pathologic tissue ECM, or decellularized tissues. Prerequisites for such extensions are the development of appropriate fluorescent analogs of the adhesion receptor of interest, and the utilization of an appropriate binding model that can describe the nature of marker binding on the matrix under investigation. Ligand density measurements can help clarify how 3D matrices modulate key cell phenotypes that affect biological processes. First, the significantly more extensive cell adhesion (adhesion of capsule cells to the scaffold inner lumen, adhesion of cells to scaffold struts as they migrate inside the scaffold) to scaffold D compared to scaffold E (Figs. 5, 6 ) could result by the increased ligand density of scaffold D (Fig. 4) . This dramatic effect in cell-scaffold adhesion cannot be explained by differences in other material properties, specifically the sevenfold increased stiffness, 13 and the increased in vivo degradation rate of scaffold E compared to scaffold D.
14 In addition, the contractile cell capsule morphology observed 9-weeks post-injury in animal group E resembles the one observed in transected PN grafted with silicone tubes, 8 materials that lack adhesion ligands, suggesting that this similarity can be explained by a paucity of adhesion ligands in scaffold E. We speculate that the limited ability of cells to bind scaffold E could lead cells to instead interact more with their surrounding cells and could possibly explain why in animal group E a thicker capsule consisting of multiple concentric layers of contractile cells forms within 1 week.
The combined observations of Figs. 4, 5, and 6 also agree with a simple mechanism that has been proposed to partly explain how biomaterials regulate the wound healing outcome. 33 This mechanism suggests that regeneration is impeded by the effects of mechanical stress fields in the wound, induced by cell forces in the contractile cell capsule. In the case of PN, elementary cell forces in the capsule sum up along the circumferential axis (hoop stresses) causing compression of the enclosed nerve tissue, which was shown to correlate inversely with the quality of the wound healing outcome. 27 Finally, the new technique offers a way for bringing materials science closer to quantitative biology. So far, any chemical stimuli provided by the surrounding matrix to cells have been described in a qualitative manner. By providing a standardized quantification of the chemical stimuli provided by a matrix to cells, the new method enables the incorporation of matrix effects in quantitative systems-level models of signal transduction. Efforts in this area have so far neglected to account for signal transduction effects of the surrounding matrix.
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